dihexa clinical trial human studies trials Dihexa Unlocking the Potential of Dihexa

Cell experiments and controlled experimental animal models can help researchers study possible mechanisms, but they cannot establish safety or effectiveness for human or veterinary use

With these capabilities, BPC 157 therapy can recover glaucomatous rats, normalize intraocular pressure, maintain retinal integrity, recover pupil function, recover retinal ischemia, and corneal injuries (i.e., maintained transparency after complete corneal abrasion, corneal ulceration, and counteracted dry eye after lacrimal gland removal or corneal insensitivity)

It must be determined that it meets at least two of the following three criteria: It has the potential to enhance or enhances sport performance It represents an actual or potential health risk to the athletes It violates the spirit of sport WADA also published: The 2025 Monitoring Program, which includes substances that are not on the List , but that WADA wishes to monitor in order to detect potential patterns of misuse in sport

Cellular Turnover and Pigmentation One of the less-publicized but clinically notable effects of GHK-Cu is its influence on cellular turnover rate